Patent · US Active

Substituted pyrazino[2,3-b]pyrazines as mTOR kinase inhibitors

US8907087B2 · kind B2 · utility

4Cited by
15References
11Claims
0Family size

Assignee

Inventors

Key dates

Filing dateJun 26, 2013
Grant dateDec 9, 2014
Priority date—
Expiry dateJun 26, 2033

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07D498/14
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

Provided herein are Heteroaryl Compounds having the following structure: Furthermore, provided are methods of preparing a compound of formula (III),Furthermore, provided are methods of preparing a compound of formula (VI),

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.